Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00275587 · ClinicalTrials.gov registry record

Development of a Hospital Service That Uses Critical Pathway (Protocolized) Care Plans to Provide High-Quality, High-Reliability, Evidence-Based Medical Care

A clinical trial of Critical Pathways, sponsored by Mayo Clinic.

Completed
Registry status
348
Enrollment target
1
Study location

NCT00275587: Completed study of Critical Pathways, sponsored by Mayo Clinic.

NCT00275587 is a study of Critical Pathways that has completed, run by Mayo Clinic. The registered enrollment target is 348 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00275587, a study of Critical Pathways, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
348 participants
Enrollment target
1
Study location

Study Summary

Our broad, long-term objective is to create a new non-resident (non-teaching) hospital service that uses patient-centered critical pathway care plans for treating patients in St. Marys Hospital. This innovative service, the Hospital Medicine (HOME) Team, will integrate three timely, high-priority concepts in healthcare: patient-centered quality care, evidence-based medicine, and principles that define high reliability organizations. The target populations for the new model of service are patients hospitalized with pre-defined admission diagnoses who are expected to require only a brief, focused hospital stay of four days or less. Specifically, we will 1) Design the prototypical approach to be used for developing all critical pathway care plans by integrating patient-centered quality care, evidence-based medicine, and principles that define high reliability organizations, 2) Systematically design the critical pathway care plans for two pre-defined admission diagnoses (community-acquired pneumonia and non-surgical low-back pain), and 3) Compare outcomes of this new service against respective historical patient cohorts for patients admitted with community-acquired pneumonia and non-surgical low-back pain. We anticipate that the prototypic methodology used to develop this patient-centered service will be replicated for other new hospital-service models. To our knowledge, there are currently no existing hospital services in the U.S. that have intentionally integrated principles of high reliability organizations into evidence-based critical pathways founded on patient-centered principles of uncompromising quality.

Conditions Studied

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 348 participants
Start Date 2005-01
Est. Completion 2008-01
Mayo Clinic

2,844 total trials

What the finished NCT00275587 record still lists

NCT00275587 is an observational study that tracks outcomes without assigning an intervention. The registered 348 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Critical Pathways appearing as the primary indexed condition, and to 0 interventions.

NCT00275587 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT00275587 about?

NCT00275587 is a clinical study titled "Development of a Hospital Service That Uses Critical Pathway (Protocolized) Care Plans to Provide High-Quality, High-Reliability, Evidence-Based Medical Care". Our broad, long-term objective is to create a new non-resident (non-teaching) hospital service that uses patient-centered critical pathway care plans for treating patients in St. Marys Hospital. This innovative service, the Hospital Medicine (HOME) Team, will integrate three timely, high-priority co...

What is the current status of trial NCT00275587?

This trial is currently completed. The enrollment target is 348 participants. The study started on 2005-01. Estimated completion is 2008-01.

What conditions does trial NCT00275587 study?

This clinical trial studies the following conditions: Critical Pathways.

Who is sponsoring clinical trial NCT00275587?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00275587 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04041479 · 348 participants · Phase 3

    Biomarker-guided rTMS for Treatment Resistant Depression

  • NCT04530565 · 348 participants · Phase 3

    Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

  • NCT05428735 · 348 participants · NA

    The DRAGON 2 Trial

  • NCT05787379 · 348 participants · NA

    Care for Veterans Post-COVID-19

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00275587, the US trial registry maintained by the National Library of Medicine. NCT00275587 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.